STOCK TITAN

Solventum (SOLV) director Carlos Alban settles 3,403 RSUs into common stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Solventum Corp director Carlos Alban exercised restricted stock units into common shares. On April 30, 2026, he converted 3,403 Restricted Stock Units, each representing one share of common stock, into 3,403 shares of Solventum common stock in a non-cash transaction at a stated price of $0.00 per unit.

The filing notes these RSUs were fully vested prior to settlement. After the exercise, Alban directly holds 8,947 shares of Solventum common stock. No open-market purchases or sales and no tax-withholding dispositions are reported in this filing, indicating a routine compensation-related equity settlement.

Positive

  • None.

Negative

  • None.

Insights

Director Alban’s Form 4 shows a routine RSU settlement with no share sales.

Carlos Alban, a director of Solventum Corp, exercised 3,403 Restricted Stock Units into an equal number of common shares on April 30, 2026. The transaction is recorded at a per-unit price of $0.00, consistent with equity awards delivered as compensation rather than market purchases.

The RSUs were disclosed as fully vested before settlement, and no remaining derivative awards are shown in this filing. Following the exercise, Alban directly owns 8,947 shares of common stock. With no open-market sales, gifts, or tax-withholding entries reported, this looks like a standard equity compensation event rather than an active change in investment stance.

Insider ALBAN CARLOS
Role null
Type Security Shares Price Value
Exercise Restricted Stock Units 3,403 $0.00 --
Exercise Common Stock 3,403 $0.00 --
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct, null); Common Stock — 8,947 shares (Direct, null)
Footnotes (1)
  1. Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. The RSUs are fully vested.
RSUs exercised 3,403 units Restricted Stock Units converted to common stock on April 30, 2026
Common shares acquired from RSUs 3,403 shares Shares of Solventum common stock received upon RSU settlement
Per-unit transaction price $0.00 per unit Reported price for RSU conversion to common stock
Shares held after transaction 8,947 shares Total direct Solventum common stock holdings after RSU exercise
Derivative positions remaining 0 units No remaining RSUs from this award in derivative summary
Restricted Stock Units financial
"Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSU financial
"Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share"
Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
exercise or conversion financial
"transaction_action: derivative exercise/conversion"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ALBAN CARLOS

(Last)(First)(Middle)
1750 YANKEE DOODLE ROAD

(Street)
EAGAN MINNESOTA 55121

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Solventum Corp [ SOLV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/30/2026M3,403A$08,947D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)04/30/2026M3,403 (2)04/30/2035Common Stock3,403$00D
Explanation of Responses:
1. Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
2. The RSUs are fully vested.
Remarks:
/s/Megan Bombick, attorney-in-fact for Carlos Alban05/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Solventum (SOLV) director Carlos Alban report in this Form 4?

Carlos Alban reported exercising 3,403 Restricted Stock Units into 3,403 shares of Solventum common stock. The transaction reflects settlement of fully vested equity awards, with no open-market purchases or sales disclosed in this specific filing.

How many Solventum (SOLV) shares does Carlos Alban hold after this transaction?

After the reported RSU exercise, Carlos Alban directly holds 8,947 shares of Solventum common stock. This total reflects his position immediately following conversion of 3,403 fully vested Restricted Stock Units into an equal number of common shares.

Was the Solventum (SOLV) Form 4 transaction an open-market buy or sell?

The Form 4 does not show any open-market buy or sell. It reports a derivative exercise, where 3,403 Restricted Stock Units converted into 3,403 common shares, recorded at a price of $0.00 per unit, typical for equity compensation settlements.

What type of security did Carlos Alban exercise at Solventum (SOLV)?

He exercised Restricted Stock Units, each representing a contingent right to receive one share of Solventum common stock upon settlement. In this filing, 3,403 fully vested RSUs converted into 3,403 common shares on April 30, 2026.

Do the Solventum (SOLV) RSUs in this filing remain outstanding after settlement?

No, the reported 3,403 Restricted Stock Units were settled into common shares and show zero remaining units afterward. The derivative summary for this filing is empty, indicating no RSUs from this award remain outstanding here.